Table 5.

Summary of clinical and social outcomes in juvenile-onset (JoAS) versus adult-onset ankylosing spondylitis (AoAS).

DomainCharacteristicJoAS More Likely/Higher/Worse (Ref. No.)Equal JoAS & AoAS (Ref. No.)AoAS More Likely/Higher/Worse (Ref. No.)
Treatment
NSAID use(13)
Treatments(5)
Medication use(9, 14)
Employment
IncomeBetter (6)
Socioeconomic status(5)
Educational levelBetter (6)(12, 14)Better (5)
In school or employment(13)
In full-time employment(9)
Unemployable due to AS(13)
Work disability(6)(14)
Health-related status
HAQ(14)(7)
Limitation of lifestyle due to AS(13)
BASG(11)(16)
PGANS (16)
Quality of life (SF-36)(5)(7)
ASQoL(12)(7)
FatigueBASDAI (12)FACIT (7)
Modified Arthritis Impact Measurement Scales (AIMS; includes depression, anxiety, physical activity, pain, impact, social activity)(9)
Social activity domain of AIMS(9)
  • NS: not statistically significant; AS: ankylosing spondylitis; ASQoL: AS quality of life index; FACIT: Functional Assessment of Chronic Illness Therapy Fatigue scale; HAQ: Health Assessment Questionnaire; PGA: Patient Global Assessment; SF-36: Medical Outcome Study Short Form-36; AIMS: Modified Arthritis Impact Measurement Scales; NSAID: nonsteroidal antiinflammatory drug; BASG: Bath AS Patient Global Score.